Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Immunological and Vascular Dysfunction in Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO PET and MRI

NCT05615415 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05615415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05615415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Immunological and Vascular Dysfunction in Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO PET and MRI
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Active, not recruiting
Start date
February 15, 2022
Completion date
December 31, 2027
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropsychiatric post-acute sequelae of sars-cov-2 infection